LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation

Patients with advanced renal cell carcinoma who are resistant to sunitinib currently have limited clinical options for treatment. Therefore, it is necessary to explore the biological basis of sunitinib resistance and to uncover new targets for the intervention of sunitinib resistance. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Gong, Liu, Yuenan, Liu, Lilong, Ruan, Hailong, Cao, Qi, Song, Zhengshuai, Bao, Lin, Xu, Tianbo, Xiong, Zhiyong, Liu, Jingchong, Liu, Di, Liang, Huageng, Jiang, Guosong, Yang, Xiong, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521490/
https://www.ncbi.nlm.nih.gov/pubmed/32921632
http://dx.doi.org/10.18632/aging.103755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521490/
https://www.ncbi.nlm.nih.gov/pubmed/32921632
http://dx.doi.org/10.18632/aging.103755

Ejemplares similares